201 related articles for article (PubMed ID: 35238624)
1. Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.
Rathbone T; Ates I; Fernando L; Addlestone E; Lee CM; Richards VP; Cottle RN
CRISPR J; 2022 Jun; 5(3):397-409. PubMed ID: 35238624
[TBL] [Abstract][Full Text] [Related]
2. Electroporation-mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes.
Rathbone T; Ates I; Stuart C; Parker T; Cottle RN
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723482
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.
Ates I; Stuart C; Rathbone T; Barzi M; He G; Major AM; Shankar V; Lyman RA; Angner SS; Mackay TFC; Srinivasan S; Farris AB; Bissig KD; Cottle RN
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38668730
[TBL] [Abstract][Full Text] [Related]
4. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
Chen S; Lee B; Lee AY; Modzelewski AJ; He L
J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
[TBL] [Abstract][Full Text] [Related]
5. Gene Editing in Green Alga Chlamydomonas reinhardtii via CRISPR-Cas9 Ribonucleoproteins.
Kelterborn S; Boehning F; Sizova I; Baidukova O; Evers H; Hegemann P
Methods Mol Biol; 2022; 2379():45-65. PubMed ID: 35188655
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral Capsid-Mediated
Lu Z; Yao X; Lyu P; Yadav M; Yoo K; Atala A; Lu B
CRISPR J; 2021 Dec; 4(6):914-928. PubMed ID: 33733873
[TBL] [Abstract][Full Text] [Related]
7. Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes.
Diallo CK; Modzelewski AJ
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591999
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887
[TBL] [Abstract][Full Text] [Related]
9. Pursuit of chlorovirus genetic transformation and CRISPR/Cas9-mediated gene editing.
Noel EA; Weeks DP; Van Etten JL
PLoS One; 2021; 16(10):e0252696. PubMed ID: 34673785
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
Hildreth AD; Riggan L; O'Sullivan TE
STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Bloomer H; Khirallah J; Li Y; Xu Q
Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
[TBL] [Abstract][Full Text] [Related]
13. Application of CRISPR/Cas9 system and the preferred no-indel end-joining repair in tardigrades.
Kumagai H; Kondo K; Kunieda T
Biochem Biophys Res Commun; 2022 Oct; 623():196-201. PubMed ID: 35926276
[TBL] [Abstract][Full Text] [Related]
14. Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs.
Stahl EC; Sabo JK; Kang MH; Allen R; Applegate E; Kim SE; Kwon Y; Seth A; Lemus N; Salinas-Rios V; Soczek KM; Trinidad M; Vo LT; Jeans C; Wozniak A; Morris T; Kimberlin A; Foti T; Savage DF; Doudna JA
Mol Ther; 2023 Aug; 31(8):2422-2438. PubMed ID: 37403358
[TBL] [Abstract][Full Text] [Related]
15. High-throughput sequencing revealed low-efficacy genome editing using Cas9 RNPs electroporation and single-celled microinjection provided an alternative to deliver CRISPR reagents into Euglena gracilis.
Chen Z; Zhu J; Chen Z; Du M; Yao R; Fu W; Lei A; Wang J
Plant Biotechnol J; 2022 Nov; 20(11):2048-2050. PubMed ID: 36036114
[No Abstract] [Full Text] [Related]
16. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
[TBL] [Abstract][Full Text] [Related]
17. Fast and efficient CRISPR-mediated genome editing in Aureobasidium using Cas9 ribonucleoproteins.
Kreuter J; Stark G; Mach RL; Mach-Aigner AR; Zimmermann C
J Biotechnol; 2022 May; 350():11-16. PubMed ID: 35398275
[TBL] [Abstract][Full Text] [Related]
18. Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells.
Tyumentseva MA; Tyumentsev AI; Akimkin VG
PLoS One; 2021; 16(11):e0259812. PubMed ID: 34752487
[TBL] [Abstract][Full Text] [Related]
19. Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins.
Metzger JM; Wang Y; Neuman SS; Snow KJ; Murray SA; Lutz CM; Bondarenko V; Felton J; Gimse K; Xie R; Li D; Zhao Y; Flowers MT; Simmons HA; Roy S; Saha K; Levine JE; Emborg ME; Gong S
Biomaterials; 2023 Feb; 293():121959. PubMed ID: 36527789
[TBL] [Abstract][Full Text] [Related]
20. A carrier-free multiplexed gene editing system applicable for suspension cells.
Ju A; Lee SW; Lee YE; Han KC; Kim JC; Shin SC; Park HJ; EunKyeong Kim E; Hong S; Jang M
Biomaterials; 2019 Oct; 217():119298. PubMed ID: 31280073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
